UNCOOKED ALERT: Indivior said to ...
Indivior, the FTSE 250-listed opiod addiction treatment company, is rumoured to be the mystery bidder circling Opiant Pharmaceuticals, the US-listed developer of medicines for drug addiction.
Date:Wednesday, 23 February 2022 3:06 pm
